Inventor · disambiguated record
Ronald G. Crystal
Also filed as: CRYSTAL RONALD · CRYSTAL RONALD G
35 granted patents·35 pending applications·1,586 citations·filing 1989–2024
98Inventor score
Files withUNIV CORNELL24CORNELL RES FOUNDATION INC19INST NAT SANTE RECH MED8US HEALTH5CRYSTAL RONALD G4
Top patents by PatentIndex Score
70 records- 0194US6127525AChimeric adenoviral coat protein and methods of using sameCORNELL RES FOUNDATION INC·Filed 1997·Granted Oct 3, 2000·139 cites·48 claims
- 0293US9066966B2Methods and pharmaceutical compositions for the treatment of cardiomyopathy due to friedreich ataxiaINST NAT SANTE RECH MED·Filed 2013·Granted Jun 30, 2015·29 cites·21 claims
- 0393US5837511ANon-group C adenoviral vectorsCORNELL RES FOUNDATION INC·Filed 1995·Granted Nov 17, 1998·289 cites·17 claims
- 0492US10337027B2Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to Friedreich ataxiaINST NAT SANTE RECH MED·Filed 2015·Granted Jul 2, 2019·13 cites·6 claims
- 0592US6013638AAdenovirus comprising deletions on the E1A, E1B and E3 regions for transfer of genes to the lungUS HEALTH·Filed 1993·Granted Jan 11, 2000·108 cites·14 claims
- 0692US5869037AAdenoviral-mediated gene transfer to adipocytesCORNELL RES FOUNDATION INC·Filed 1996·Granted Feb 9, 1999·167 cites·10 claims
- 0790US12122844B2Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodiesUNIV CORNELL·Filed 2020·Granted Oct 22, 2024·2 cites·14 claims
- 0888US2025109408A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 0987US6153435ANucleic acid that encodes a chimeric adenoviral coat proteinCORNELL RES FOUNDATION INC·Filed 1999·Granted Nov 28, 2000·64 cites·32 claims
- 1087US2025109407A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2024·Application pending·0 cites
- 1183US11821009B2Genetic modification of the AAV capsid resulting in altered tropism and enhanced vector deliveryUNIV CORNELL·Filed 2019·Granted Nov 21, 2023·3 cites·19 claims
- 1283US6508802B1Remote sensing gene therapy delivery device and method of administering a therapeutic solution to a heartCORNELL RES FOUNDATION INC·Filed 2000·Granted Jan 21, 2003·151 cites·40 claims
- 1383US6322536B1Minimally invasive gene therapy delivery and methodCORNELL RES FOUNDATION INC·Filed 1999·Granted Nov 27, 2001·178 cites·31 claims
- 1482US5928944AMethod of adenoviral-medicated cell transfectionUS HEALTH·Filed 1994·Granted Jul 27, 1999·90 cites·50 claims
- 1581US9682133B2Disrupted adenovirus-based vaccine against drugs of abuseCRYSTAL RONALD G·Filed 2011·Granted Jun 20, 2017·9 cites·15 claims
- 1679US7863425B2Compositions and methods for inhibiting Yersinia pestis infectionUNIV CORNELL·Filed 2008·Granted Jan 4, 2011·2 cites·2 claims
- 1778US5618786AAerosolization of protein therapeutic agentCOOPER LAB·Filed 1994·Granted Apr 8, 1997·68 cites·10 claims
- 1876US10946094B2Adenoassociated viral mediated persistant anti-VEGF therapy for ovarian cancerUNIV CORNELL·Filed 2016·Granted Mar 16, 2021·2 cites·2 claims
- 1976US10214731B2Adeno-associated virus mediated delivery of C1E1 as a therapy for angioedemaUNIV CORNELL·Filed 2016·Granted Feb 26, 2019·2 cites·14 claims
- 2075US5238683AAerosol preparation of glutathione and a method for augmenting glutathione level in lungsUS HEALTH·Filed 1989·Granted Aug 24, 1993·37 cites·5 claims
- 2175US2022090128A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2021·Application pending·0 cites
- 2275US2021340565A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2020·Application pending·0 cites
- 2374US12024568B2Treatment of brain cancers using central nervous system mediated gene transfer of monoclonal antibodiesCRYSTAL RONALD G·Filed 2013·Granted Jul 2, 2024·2 cites·10 claims
- 2474US10093947B2AAV-directed persistent expression of an anti-nicotine antibody gene for smoking cessationUNIV CORNELL·Filed 2013·Granted Oct 9, 2018·1 cites·12 claims
- 2574US5989521AMethod for augmenting a decreased level of reduced glutathione in the lungUS HEALTH·Filed 1991·Granted Nov 23, 1999·24 cites·15 claims
- 2672US10383916B2Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardiumUNIV CORNELL·Filed 2013·Granted Aug 20, 2019·1 cites·10 claims
- 2772US2020157564A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2019·Application pending·0 cites
- 2869US10293059B2Gene therapy to prevent reactions to allergensUNIV CORNELL·Filed 2016·Granted May 21, 2019·1 cites·27 claims
- 2969US6329348B1Method of inducing angiogenesisCORNELL RES FOUNDATION INC·Filed 1999·Granted Dec 11, 2001·26 cites·21 claims
- 3069US6159950AMethod of modulating hair growthCORNELL RES FOUNDATION INC·Filed 1998·Granted Dec 12, 2000·37 cites·8 claims
- 3166US6939540B1Method of enhancing bone densityGENVEC INC·Filed 2000·Granted Sep 6, 2005·2 cites·37 claims
- 3266US2022088143A1Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardiumUNIV CORNELL·Filed 2021·Application pending·0 cites
- 3365US5997509AMinimally invasive gene therapy delivery device and methodCORNELL RES FOUNDATION INC·Filed 1998·Granted Dec 7, 1999·109 cites·20 claims
- 3464US2019358297A1Angiogenic conditioning to enhance cardiac cellular reprogramming of fibroblasts of the infarcted myocardiumUNIV CORNELL·Filed 2019·Application pending·0 cites
- 3564US2018334687A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureINST NAT SANTE RECH MED·Filed 2018·Application pending·0 cites
- 3662US7687613B2Genetic vaccines directed against bacterial exotoxinsCORNELL RES FOUNDATION INC·Filed 2003·Granted Mar 30, 2010·1 cites·13 claims
- 3761US7368553B2Alternatively spliced nucleic acid moleculesCORNELL RES FOUNDATION INC·Filed 2004·Granted May 6, 2008·1 cites·8 claims
- 3861US2016024526A1Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failureAPHP ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS·Filed 2014·Application pending·0 cites
- 3960US2025161483A1Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy associated with friedreich ataxiaLEXEO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4060US2020172605A1Gene therapy for alzheimer's and other neurodegenerative diseases and conditionsUNIV CORNELL·Filed 2019·Application pending·0 cites
- 4159US10004811B2Development of a highly efficient second generation nicotine-conjugate vaccine to treat nicotine addictionUNIV CORNELL·Filed 2013·Granted Jun 26, 2018·0 cites·13 claims
- 4258US2024307517A1Development of a highly efficient second generation fentanyl-conjugate vaccine to treat fentanyl addictionUNIV CORNELL·Filed 2022·Application pending·0 cites
- 4358US2016355573A1Gene therapy for alzheimer's and other neurodegenerative diseases and conditionsUNIV CORNELL·Filed 2014·Application pending·0 cites
- 4457US2003103943A1Multiple site delivery of adenoviral vector for the induction of angiogenesisCORNELL RES FOUNDATION INC·Filed 2003·Application pending·0 cites
- 4556US2011086063A1Vaccines for prevention and treatment of addictionUNIV CORNELL·Filed 2009·Application pending·0 cites
- 4655US6518255B2Multiple site delivery of adenoviral vector directly into muscle for the induction of angiogenesisCORNELL RES FOUNDATION INC·Filed 1999·Granted Feb 11, 2003·13 cites·96 claims
- 4754US12226492B2Gene therapy for eosinophilic disordersUNIV CORNELL·Filed 2018·Granted Feb 18, 2025·0 cites·20 claims
- 4853US2002164304A1Adenovirus-mediated transfer of genes to the lungTRANSGENE·Filed 2001·Application pending·0 cites
- 4953US2003202963A1Method of treating cancerCORNELL RES FOUNDATION INC·Filed 2003·Application pending·0 cites
- 5053US2023044351A1Apoe gene therapyUNIV CORNELL·Filed 2020·Application pending·0 cites
Showing the top 50 of 70 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ronald G. Crystal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →